EUVIMEDEUVIMED entdecken
Crossref

The activated partial thromboplastin time‐clot waveform analysis in hemophilia: Does it help in differentiation?

Khalid Abdul Mannan, Narender Kumar iD, Jasmina Ahluwalia, Chander Hans, Anita Kler, Gaurav Prakash, Richa Jain

International Journal of Laboratory Hematology · 2023-04 · 45 (2) · 241-249

DOI: 10.1111/ijlh.14008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 10.12.2022. Verfasst von Khalid Abdul Mannan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India. Hauptthemen laut MEDLINE: Hemophilia A, Thrombosis, Hemophilia B. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The clot waveform analysis (CWA) provide valuable information beyond clotting time. The present study was planned to assess whether the activated partial thromboplastin time (aPTT)‐CWA can differentiate between hemophilia A (HA), hemophilia B (HB), or hemophilia A with inhibitors (HAWI).

Methods

The aPTT‐CWA was generated by an optical detection system (ACL‐TOP™ 500 coagulation analyzer) and the other tests were performed as per instructions from the manufacturer in the kit.

Results

A total of 75 samples (47‐HA, 16‐HAWI, and 12‐HB) with prolonged aPTT were recruited. On analyzing the quantitative aPTT‐CWA data of HA (non‐inhibitors) and HB samples, the width of acceleration 1 [+] peak was the differentiating finding. Among the significant parameters, the second derivative [+] peak was lower in both mild and moderate HA, equating to HB. The time for the height of 1/2 fibrin formation and width of velocity was significantly higher in mild, moderate and severe HA. The study did not show any significant differentiating finding while comparing HAWI and hemophilia A non‐inhibitors (HANI). In the subgroups of HAWI and HANI with aPTT

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AThrombosisHemophilia BHumansPartial Thromboplastin TimeBlood Coagulation TestsFibrin

Stichwörter der Autor:innen

activated partial thromboplastin timeclot waveform analysishemophiliainhibitor

Substanzen

Fibrin

Autor:innen und Institutionen

  • Department of Hematology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India.
  • Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India.
  • Department of Pediatric Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India.

ORCID-Profile: Narender Kumar

Zitieren

APA

Mannan, K. A., Kumar, N., Ahluwalia, J., Hans, C., Kler, A., Prakash, G., & Jain, R. (2023). The activated partial thromboplastin time‐clot waveform analysis in hemophilia: Does it help in differentiation?. International Journal of Laboratory Hematology, 45(2), 241-249. https://doi.org/10.1111/ijlh.14008

Vancouver

Mannan KA, Kumar N, Ahluwalia J, Hans C, Kler A, Prakash G, et al. The activated partial thromboplastin time‐clot waveform analysis in hemophilia: Does it help in differentiation?. International Journal of Laboratory Hematology. 2023;45(2):241-249. doi:10.1111/ijlh.14008

BibTeX
@article{Mannan2023,
  author = {Mannan, Khalid Abdul and Kumar, Narender and Ahluwalia, Jasmina and Hans, Chander and Kler, Anita and Prakash, Gaurav and Jain, Richa},
  title = {The activated partial thromboplastin time‐clot waveform analysis in hemophilia: Does it help in differentiation?},
  journal = {International Journal of Laboratory Hematology},
  year = {2023},
  volume = {45},
  number = {2},
  pages = {241--249},
  doi = {10.1111/ijlh.14008}
}
Kostenlos starten →